Biology And Management Of Multiple Myeloma
DOWNLOAD
Download Biology And Management Of Multiple Myeloma PDF/ePub or read online books in Mobi eBooks. Click Download or Read Online button to get Biology And Management Of Multiple Myeloma book now. This website allows unlimited access to, at the time of writing, more than 1.5 million titles, including hundreds of thousands of titles in various foreign languages. If the content not found or just blank you must refresh this page
Biology And Management Of Multiple Myeloma
DOWNLOAD
Author : James R. Berenson
language : en
Publisher: Springer Science & Business Media
Release Date : 2004-05-14
Biology And Management Of Multiple Myeloma written by James R. Berenson and has been published by Springer Science & Business Media this book supported file pdf, txt, epub, kindle and other format this book has been release on 2004-05-14 with Medical categories.
Expert physicians and clinical researchers summarize and explain all the recent advances in the biology and treatment of bone marrow-based malignancy. On the biological side, the authors show the characteristics of the malignant cell and describe the significant roles played by oncogenic changes, chromosomal anomalies, Kaposi's sarcoma herpes virus, and cytokines. New epidemiological findings and prognostic factors are also analyzed. On the clinical side, the authors provide a comprehensive review of conventional treatment regimens, as well as a discussion of newer experimental approaches involving immunologic targeting, inhibitors of drug resistance, and antitumor agents.
Biology And Management Of Multiple Myeloma
DOWNLOAD
Author : James Berenson
language : en
Publisher:
Release Date : 2014-01-15
Biology And Management Of Multiple Myeloma written by James Berenson and has been published by this book supported file pdf, txt, epub, kindle and other format this book has been release on 2014-01-15 with categories.
Myeloma
DOWNLOAD
Author : J. S. Malpas
language : en
Publisher: Elsevier Health Sciences
Release Date : 2004
Myeloma written by J. S. Malpas and has been published by Elsevier Health Sciences this book supported file pdf, txt, epub, kindle and other format this book has been release on 2004 with Medical categories.
This book was prompted by a renewed interest in the biology of myeloma, new concepts with regard to its clinical evolution, and options for therapy that have not been available before. Myeloma has always involved many systems and caused many problems for the clinician. It has become a focus of attention for the scientist and clinician.
Biology And Management Of Unusual Plasma Cell Dyscrasias
DOWNLOAD
Author : Todd M. Zimmerman
language : en
Publisher: Springer
Release Date : 2016-09-17
Biology And Management Of Unusual Plasma Cell Dyscrasias written by Todd M. Zimmerman and has been published by Springer this book supported file pdf, txt, epub, kindle and other format this book has been release on 2016-09-17 with Medical categories.
This unique book focuses on the non-myeloma plasma cell dyscrasias. A key resource for this group of diseases, the book features the latest in emerging knowledge and therapeutic developments, including novel therapies. Each disease-specific chapter discusses biology, disease course, and appropriate therapeutic interventions, covering plasma cell leukemia, plasmacytoma, POEMS Syndrome and Castleman's Disease, Waldenström macroglobulinemia, immunoglobin deposition disease, and cryoglobulinemic syndromes, among others. The only book dedicated to this intriguing family of diseases, Biology and Management of Unusual Plasma Cell Dyscrasias will be a long-lasting reference for clinicians and scientists alike.
Advances In Biology And Therapy Of Multiple Myeloma
DOWNLOAD
Author : Nikhil C. Munshi
language : en
Publisher: Springer Science & Business Media
Release Date : 2012-11-15
Advances In Biology And Therapy Of Multiple Myeloma written by Nikhil C. Munshi and has been published by Springer Science & Business Media this book supported file pdf, txt, epub, kindle and other format this book has been release on 2012-11-15 with Medical categories.
Despite the advances in conventional, novel agent and high dose chemotherapy multiple myeloma (MM) remains incurable. In order to overcome resistance to current therapies and improve patient outcome, novel biologically-based treatment approaches are being developed. Current translational research in MM focusing on the development of molecularly-based combination therapies has great promise to achieve high frequency and durable responses in the majority of patients. Two major advances are making this goal possible. First, recent advances in genomics and proteomics in MM have allowed for increased understanding of disease pathogenesis, identified novel therapeutic targets, allowed for molecular classification, and provided the scientific rationale for combining targeted therapies to increase tumor cell cytotoxicity and abrogate drug resistance. Second, there is now an increased understanding of how adhesion of MM cells in bone marrow (BM) further impacts gene expression in MM cells, as well as in BM stromal cells (BMSCs). As a result of these advances in oncogenomics on the one hand and increased understanding of the role of the BM in the pathogenesis of MM on the other, a new treatment paradigm targeting the tumor cell and its BM microenvironment to overcome drug resistance and improve patient outcome has now been developed. Thalidomide, lenalidomide, and Bortezomib are three agents which target the tumor cell in its microenvironment in both laboratory and animal models and which have rapidly translated from the bench to the bedside. Ongoing efforts are using oncogenomics and cell signaling studies to identify next generation of therapies in MM on the one hand, and to inform the design of combination trials on the other. This new paradigm for overcoming drug resistance and improving patient outcome in MM has great promise not only to change the natural history of MM, but also to serve as a model for targeted therapeutics directed to improve outcome of patients with MM.
Myeloma
DOWNLOAD
Author : J. S. Malpas
language : en
Publisher: Oxford University Press, USA
Release Date : 1995
Myeloma written by J. S. Malpas and has been published by Oxford University Press, USA this book supported file pdf, txt, epub, kindle and other format this book has been release on 1995 with Medical categories.
The past few years have seen a rapidly developing interest in myeloma. There has been an explosion of new knowledge in the biology of the myeloma cell, and the first indications have appeared that some of this knowledge could be clinically applied. Newly accepted and successful treatments are now changing established practice in the therapy of myeloma. This book provides a major, comprehensive text on multiple myeloma. It covers pathophysiology, clincial features, complications and management, and is an authoritative guide to clinical practice, with a strong emphasis on the fundamental biology which underlies the disease.
Contemporary Management Of Multiple Myeloma
DOWNLOAD
Author : Ravi Vij
language : en
Publisher: JP Medical Ltd
Release Date : 2011-11-08
Contemporary Management Of Multiple Myeloma written by Ravi Vij and has been published by JP Medical Ltd this book supported file pdf, txt, epub, kindle and other format this book has been release on 2011-11-08 with Medical categories.
This book is a practical guide to multiple myeloma. Beginning with the epidemiology, etiology and biology of the disease, the text then discusses clinical scenarios, diagnosis and various treatment options, including induction therapy, hematopoietic stem cell transplantation and treatment of relapsed/refractory cases. Authored by a US-based specialist, this book provides 166 detailed illustrations, tables, figures and algorithms to help understanding.
Epidemiology And Biology Of Multiple Myeloma
DOWNLOAD
Author : G. Iris Obrams
language : en
Publisher: Springer Science & Business Media
Release Date : 2012-12-06
Epidemiology And Biology Of Multiple Myeloma written by G. Iris Obrams and has been published by Springer Science & Business Media this book supported file pdf, txt, epub, kindle and other format this book has been release on 2012-12-06 with Medical categories.
On March 27, 1990, the National Cancer Institute sponsored a workshop on the epidemiology of multiple myeloma, held at the National Institutes of Health. This book comprises articles prepared by participants in this work shop. Discussed in these papers are: the descriptive and analytic epidemi ology, differences in risk factors between blacks and whites, monoclonal gammopathies and their progression, and hypotheses regarding the etiology and pathogenesis of multiple myeloma. Several epidemiologic research areas received particular attention during this workshop, and are reviewed in detail in this volume. There have been striking increases in the incidence of multiple myeloma over the past thirty years, especially among older individuals and blacks, which may not be entirely explained by changes in diagnostic capabilities. Occupational and environmental exposures have been associated with an increased risk of multiple myeloma, including farming exposures, occupational exposure to petroleum and rubber processing, exposure to ionizing radiation, and asso ciations with persistent virus infections. The most striking epidemiological finding is reflected in the differences in incidence rates of multiple myeloma which are twice as high in blacks as compared with whites. Further, since 1950 the mortality rates for multiple myeloma have quadrupled in blacks while doubling for whites. Among hematopoietic malignancies, multiple myeloma is the only one with increased incidence and mortality rates among blacks. 1\vo major possibilities for explaining ethnic/racial differences in suscepti bility to multiple myeloma are genetic and environmental factors.
Update On Multiple Myeloma
DOWNLOAD
Author : Khalid Ahmed Al-Anazi
language : en
Publisher:
Release Date : 2019-02
Update On Multiple Myeloma written by Khalid Ahmed Al-Anazi and has been published by this book supported file pdf, txt, epub, kindle and other format this book has been release on 2019-02 with Neoplasms. Tumors. Oncology. Including cancer and carcinogens categories.
This book is a comprehensive overview of the recent developments in the clinical and research fields of multiple myeloma. It is divided into three main sections that cover a wide range of topics, including: epidemiology and pathogenesis of the disease, genetic targets and pathways, resistance to novel therapies, angiogenesis and anti-angiogenesis, hematopoietic stem cell transplantation, role of radiology and radiotherapy in myeloma, infectious complications, and management of multiple myeloma in resource-poor countries.
Myeloma Therapy
DOWNLOAD
Author : Sagar Lonial
language : en
Publisher: Springer Science & Business Media
Release Date : 2009-01-01
Myeloma Therapy written by Sagar Lonial and has been published by Springer Science & Business Media this book supported file pdf, txt, epub, kindle and other format this book has been release on 2009-01-01 with Medical categories.
Therapeutic options for patients with myeloma have dramatically changed over the past 10 years. Beginning with the advances in therapy resulting from the use of high-dose therapy and autologous bone marrow or stem cell tra- plant, we have more than doubled the median survival for patients as a whole, and have now have a wealth of different biology -based treatment approaches for our patients in all disease stages. This book represents state-of-the-art information from many of the leaders in the plasma cell disorders world. Sections focusing on disease pathogenesis and biology, chemotherapy-based approaches, immune -based therapies, currently approved novel agents, developing targets, supportive care, and other plasma cell disorders provides a comprehensive collection and an excellent resource in this time of rapid change in clinical and preclinical disease knowledge. It is important to realize that these changes did not occur in a vacuum. Partnerships between academic institutions, the pharmaceutical industry, patient advocacy groups, the National Cancer Institute, community onco- gists, and ultimately our patients worked closely together to realize these advances, and to effect the radical changes in therapy we have witnessed over the past few years. This book would not have been possible without contri- tions from each of the gifted scientists and clinicians who worked tirelessly to prepare their individual chapters all the while maintaining commitment to the scientific and clinical mission of advancing care.